政策推动健康医疗大数据共享 网售处方药迎解禁?

2016-06-29 佚名 北京商报

健康医疗大数据应用加速让移动医疗行业迎来利好。国务院办公厅日前印发《关于促进和规范健康医疗大数据应用发展的指导意见》(以下简称“意见”),意见中指出,将建立健全健康医疗大数据开放、保护等法规制度;到2017年底,基本形成跨部门健康医疗数据资源共享共用格局。业内人士预测,网售处方药将在2018年迎来解禁曙光。 健康医疗大数据被视为激发深化医药卫生体制改革的重要举措。意见中提出,将加快建设和完善以居

健康医疗大数据应用加速让移动医疗行业迎来利好。国务院办公厅日前印发《关于促进和规范健康医疗大数据应用发展的指导意见》(以下简称“意见”),意见中指出,将建立健全健康医疗大数据开放、保护等法规制度;到2017年底,基本形成跨部门健康医疗数据资源共享共用格局。业内人士预测,网售处方药将在2018年迎来解禁曙光。

健康医疗大数据被视为激发深化医药卫生体制改革的重要举措。意见中提出,将加快建设和完善以居民电子健康档案、电子病历、电子处方等为核心的基础数据库。鼓励各类医疗卫生机构推进健康医疗大数据采集、存储,加强应用支撑和运维技术保障,打通数据资源共享通道。到2017年底,实现国家和省级人口健康信息平台以及全国药品招标采购业务应用平台互联互通,基本形成跨部门健康医疗数据资源共享共用格局。

构建健康医疗大数据共享平台对于移动医疗和医药电商行业有着重大意义。在目前的医疗行业中,处方信息多掌握在医院手中,需要由执业药师开具。一位医药电商平台负责人表示,如果能够实现电子处方共享,便意味着医院处方外流,对移动医疗企业来说是巨大的红利。同时,规范健康医疗大数据应用的意见也向医药电商行业释放了积极信号,随着跨部门健康医疗数据资源共享共用格局的形成,这或许会推动网售处方药加速解禁。

销售处方药一直是多数医药电商难以触及的“禁区”。根据国家食品药品监督管理总局2014年公布的《互联网食品药品经营监督管理办法(征求意见稿)》,互联网药品经营者应当按照药品分类管理规定的要求,凭处方销售处方药。这项规定被业内视为处方药可以在网上销售的依据,但在过去两年中,网售处方药未能取得突破性进展。

一位医药领域研究人士表示,一旦电子处方放开,最直观的好处就是老百姓根据医生开具的电子处方,可以在药店、网上等医院以外的地方买药,避免在医院排长队等问题。

事实上,在新医改加速落地的浪潮下,已有连锁药店通过联合互联网企业开始探索创新模式。此前,老百姓大药房与互联网医院平台微医达成合作,通过药店+在线问诊模式抢占处方药市场。

互联网医疗大事记

2014年5月

国家食药监总局公布《互联网食品药品经营监督管理办法(征求意见稿)》,互联网药品经营者应凭处方销售处方药

2015年7-9月

国务院出台《关于积极推进“互联网+”行动的指导意见》,提出发展基于互联网的医疗卫生服务,探索电子处方等网络医疗健康服务应用

2015年12月

乌镇互联网医院开出了第一张互联网医院电子处方

2016年6月

国务院办公厅印发《关于促进和规范健康医疗大数据应用发展的指导意见》,2017年底基本形成跨部门健康医疗数据资源共享共用(生物谷 Bioon.com)

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1735948, encodeId=a2b41e35948b9, content=<a href='/topic/show?id=21be3492589' target=_blank style='color:#2F92EE;'>#医疗大数据#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34925, encryptionId=21be3492589, topicName=医疗大数据)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Tue Feb 28 21:30:00 CST 2017, time=2017-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2045984, encodeId=1e9e20459841b, content=<a href='/topic/show?id=2cc92e76464' target=_blank style='color:#2F92EE;'>#健康医疗大数据#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27764, encryptionId=2cc92e76464, topicName=健康医疗大数据)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=685a124, createdName=muzishouyi, createdTime=Sat Jan 21 19:30:00 CST 2017, time=2017-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1807264, encodeId=656c180e2644b, content=<a href='/topic/show?id=bd19e94520e' target=_blank style='color:#2F92EE;'>#网售处方#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79452, encryptionId=bd19e94520e, topicName=网售处方)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/TnzXXl41yf6V8fHrDb5JdtxOgpaY6vplUhHtL8BzDh1xMtcap9H1IOlE8umxPGovhIuVkeGTY26eNUFCFaOheQ/132, createdBy=29702500197, createdName=ms6279672939590805, createdTime=Sat Apr 22 12:30:00 CST 2017, time=2017-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1677589, encodeId=a17e16e758997, content=<a href='/topic/show?id=51162e76305' target=_blank style='color:#2F92EE;'>#健康医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27763, encryptionId=51162e76305, topicName=健康医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2fd27558420, createdName=jiadan198791, createdTime=Tue Mar 07 08:30:00 CST 2017, time=2017-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1695594, encodeId=92bf16955945c, content=<a href='/topic/show?id=af2ae94539a' target=_blank style='color:#2F92EE;'>#网售处方药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79453, encryptionId=af2ae94539a, topicName=网售处方药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Wed Dec 07 17:30:00 CST 2016, time=2016-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1260185, encodeId=416c12601850b, content=<a href='/topic/show?id=1ed65e476b8' target=_blank style='color:#2F92EE;'>#政策#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57476, encryptionId=1ed65e476b8, topicName=政策)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=322359, createdName=bioon3, createdTime=Fri Jul 01 02:30:00 CST 2016, time=2016-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1591253, encodeId=7ed81591253d6, content=<a href='/topic/show?id=436d299e33d' target=_blank style='color:#2F92EE;'>#共享#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29973, encryptionId=436d299e33d, topicName=共享)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec1e17938205, createdName=chendoc248, createdTime=Fri Jul 01 02:30:00 CST 2016, time=2016-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1593836, encodeId=6d351593836b6, content=<a href='/topic/show?id=a8585e72779' target=_blank style='color:#2F92EE;'>#数据共享#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57727, encryptionId=a8585e72779, topicName=数据共享)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c28e18169649, createdName=dinorsor530, createdTime=Fri Jul 01 02:30:00 CST 2016, time=2016-07-01, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1735948, encodeId=a2b41e35948b9, content=<a href='/topic/show?id=21be3492589' target=_blank style='color:#2F92EE;'>#医疗大数据#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34925, encryptionId=21be3492589, topicName=医疗大数据)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Tue Feb 28 21:30:00 CST 2017, time=2017-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2045984, encodeId=1e9e20459841b, content=<a href='/topic/show?id=2cc92e76464' target=_blank style='color:#2F92EE;'>#健康医疗大数据#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27764, encryptionId=2cc92e76464, topicName=健康医疗大数据)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=685a124, createdName=muzishouyi, createdTime=Sat Jan 21 19:30:00 CST 2017, time=2017-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1807264, encodeId=656c180e2644b, content=<a href='/topic/show?id=bd19e94520e' target=_blank style='color:#2F92EE;'>#网售处方#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79452, encryptionId=bd19e94520e, topicName=网售处方)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/TnzXXl41yf6V8fHrDb5JdtxOgpaY6vplUhHtL8BzDh1xMtcap9H1IOlE8umxPGovhIuVkeGTY26eNUFCFaOheQ/132, createdBy=29702500197, createdName=ms6279672939590805, createdTime=Sat Apr 22 12:30:00 CST 2017, time=2017-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1677589, encodeId=a17e16e758997, content=<a href='/topic/show?id=51162e76305' target=_blank style='color:#2F92EE;'>#健康医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27763, encryptionId=51162e76305, topicName=健康医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2fd27558420, createdName=jiadan198791, createdTime=Tue Mar 07 08:30:00 CST 2017, time=2017-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1695594, encodeId=92bf16955945c, content=<a href='/topic/show?id=af2ae94539a' target=_blank style='color:#2F92EE;'>#网售处方药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79453, encryptionId=af2ae94539a, topicName=网售处方药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Wed Dec 07 17:30:00 CST 2016, time=2016-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1260185, encodeId=416c12601850b, content=<a href='/topic/show?id=1ed65e476b8' target=_blank style='color:#2F92EE;'>#政策#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57476, encryptionId=1ed65e476b8, topicName=政策)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=322359, createdName=bioon3, createdTime=Fri Jul 01 02:30:00 CST 2016, time=2016-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1591253, encodeId=7ed81591253d6, content=<a href='/topic/show?id=436d299e33d' target=_blank style='color:#2F92EE;'>#共享#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29973, encryptionId=436d299e33d, topicName=共享)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec1e17938205, createdName=chendoc248, createdTime=Fri Jul 01 02:30:00 CST 2016, time=2016-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1593836, encodeId=6d351593836b6, content=<a href='/topic/show?id=a8585e72779' target=_blank style='color:#2F92EE;'>#数据共享#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57727, encryptionId=a8585e72779, topicName=数据共享)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c28e18169649, createdName=dinorsor530, createdTime=Fri Jul 01 02:30:00 CST 2016, time=2016-07-01, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1735948, encodeId=a2b41e35948b9, content=<a href='/topic/show?id=21be3492589' target=_blank style='color:#2F92EE;'>#医疗大数据#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34925, encryptionId=21be3492589, topicName=医疗大数据)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Tue Feb 28 21:30:00 CST 2017, time=2017-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2045984, encodeId=1e9e20459841b, content=<a href='/topic/show?id=2cc92e76464' target=_blank style='color:#2F92EE;'>#健康医疗大数据#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27764, encryptionId=2cc92e76464, topicName=健康医疗大数据)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=685a124, createdName=muzishouyi, createdTime=Sat Jan 21 19:30:00 CST 2017, time=2017-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1807264, encodeId=656c180e2644b, content=<a href='/topic/show?id=bd19e94520e' target=_blank style='color:#2F92EE;'>#网售处方#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79452, encryptionId=bd19e94520e, topicName=网售处方)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/TnzXXl41yf6V8fHrDb5JdtxOgpaY6vplUhHtL8BzDh1xMtcap9H1IOlE8umxPGovhIuVkeGTY26eNUFCFaOheQ/132, createdBy=29702500197, createdName=ms6279672939590805, createdTime=Sat Apr 22 12:30:00 CST 2017, time=2017-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1677589, encodeId=a17e16e758997, content=<a href='/topic/show?id=51162e76305' target=_blank style='color:#2F92EE;'>#健康医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27763, encryptionId=51162e76305, topicName=健康医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2fd27558420, createdName=jiadan198791, createdTime=Tue Mar 07 08:30:00 CST 2017, time=2017-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1695594, encodeId=92bf16955945c, content=<a href='/topic/show?id=af2ae94539a' target=_blank style='color:#2F92EE;'>#网售处方药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79453, encryptionId=af2ae94539a, topicName=网售处方药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Wed Dec 07 17:30:00 CST 2016, time=2016-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1260185, encodeId=416c12601850b, content=<a href='/topic/show?id=1ed65e476b8' target=_blank style='color:#2F92EE;'>#政策#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57476, encryptionId=1ed65e476b8, topicName=政策)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=322359, createdName=bioon3, createdTime=Fri Jul 01 02:30:00 CST 2016, time=2016-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1591253, encodeId=7ed81591253d6, content=<a href='/topic/show?id=436d299e33d' target=_blank style='color:#2F92EE;'>#共享#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29973, encryptionId=436d299e33d, topicName=共享)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec1e17938205, createdName=chendoc248, createdTime=Fri Jul 01 02:30:00 CST 2016, time=2016-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1593836, encodeId=6d351593836b6, content=<a href='/topic/show?id=a8585e72779' target=_blank style='color:#2F92EE;'>#数据共享#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57727, encryptionId=a8585e72779, topicName=数据共享)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c28e18169649, createdName=dinorsor530, createdTime=Fri Jul 01 02:30:00 CST 2016, time=2016-07-01, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1735948, encodeId=a2b41e35948b9, content=<a href='/topic/show?id=21be3492589' target=_blank style='color:#2F92EE;'>#医疗大数据#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34925, encryptionId=21be3492589, topicName=医疗大数据)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Tue Feb 28 21:30:00 CST 2017, time=2017-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2045984, encodeId=1e9e20459841b, content=<a href='/topic/show?id=2cc92e76464' target=_blank style='color:#2F92EE;'>#健康医疗大数据#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27764, encryptionId=2cc92e76464, topicName=健康医疗大数据)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=685a124, createdName=muzishouyi, createdTime=Sat Jan 21 19:30:00 CST 2017, time=2017-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1807264, encodeId=656c180e2644b, content=<a href='/topic/show?id=bd19e94520e' target=_blank style='color:#2F92EE;'>#网售处方#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79452, encryptionId=bd19e94520e, topicName=网售处方)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/TnzXXl41yf6V8fHrDb5JdtxOgpaY6vplUhHtL8BzDh1xMtcap9H1IOlE8umxPGovhIuVkeGTY26eNUFCFaOheQ/132, createdBy=29702500197, createdName=ms6279672939590805, createdTime=Sat Apr 22 12:30:00 CST 2017, time=2017-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1677589, encodeId=a17e16e758997, content=<a href='/topic/show?id=51162e76305' target=_blank style='color:#2F92EE;'>#健康医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27763, encryptionId=51162e76305, topicName=健康医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2fd27558420, createdName=jiadan198791, createdTime=Tue Mar 07 08:30:00 CST 2017, time=2017-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1695594, encodeId=92bf16955945c, content=<a href='/topic/show?id=af2ae94539a' target=_blank style='color:#2F92EE;'>#网售处方药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79453, encryptionId=af2ae94539a, topicName=网售处方药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Wed Dec 07 17:30:00 CST 2016, time=2016-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1260185, encodeId=416c12601850b, content=<a href='/topic/show?id=1ed65e476b8' target=_blank style='color:#2F92EE;'>#政策#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57476, encryptionId=1ed65e476b8, topicName=政策)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=322359, createdName=bioon3, createdTime=Fri Jul 01 02:30:00 CST 2016, time=2016-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1591253, encodeId=7ed81591253d6, content=<a href='/topic/show?id=436d299e33d' target=_blank style='color:#2F92EE;'>#共享#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29973, encryptionId=436d299e33d, topicName=共享)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec1e17938205, createdName=chendoc248, createdTime=Fri Jul 01 02:30:00 CST 2016, time=2016-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1593836, encodeId=6d351593836b6, content=<a href='/topic/show?id=a8585e72779' target=_blank style='color:#2F92EE;'>#数据共享#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57727, encryptionId=a8585e72779, topicName=数据共享)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c28e18169649, createdName=dinorsor530, createdTime=Fri Jul 01 02:30:00 CST 2016, time=2016-07-01, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1735948, encodeId=a2b41e35948b9, content=<a href='/topic/show?id=21be3492589' target=_blank style='color:#2F92EE;'>#医疗大数据#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34925, encryptionId=21be3492589, topicName=医疗大数据)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Tue Feb 28 21:30:00 CST 2017, time=2017-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2045984, encodeId=1e9e20459841b, content=<a href='/topic/show?id=2cc92e76464' target=_blank style='color:#2F92EE;'>#健康医疗大数据#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27764, encryptionId=2cc92e76464, topicName=健康医疗大数据)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=685a124, createdName=muzishouyi, createdTime=Sat Jan 21 19:30:00 CST 2017, time=2017-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1807264, encodeId=656c180e2644b, content=<a href='/topic/show?id=bd19e94520e' target=_blank style='color:#2F92EE;'>#网售处方#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79452, encryptionId=bd19e94520e, topicName=网售处方)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/TnzXXl41yf6V8fHrDb5JdtxOgpaY6vplUhHtL8BzDh1xMtcap9H1IOlE8umxPGovhIuVkeGTY26eNUFCFaOheQ/132, createdBy=29702500197, createdName=ms6279672939590805, createdTime=Sat Apr 22 12:30:00 CST 2017, time=2017-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1677589, encodeId=a17e16e758997, content=<a href='/topic/show?id=51162e76305' target=_blank style='color:#2F92EE;'>#健康医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27763, encryptionId=51162e76305, topicName=健康医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2fd27558420, createdName=jiadan198791, createdTime=Tue Mar 07 08:30:00 CST 2017, time=2017-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1695594, encodeId=92bf16955945c, content=<a href='/topic/show?id=af2ae94539a' target=_blank style='color:#2F92EE;'>#网售处方药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79453, encryptionId=af2ae94539a, topicName=网售处方药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Wed Dec 07 17:30:00 CST 2016, time=2016-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1260185, encodeId=416c12601850b, content=<a href='/topic/show?id=1ed65e476b8' target=_blank style='color:#2F92EE;'>#政策#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57476, encryptionId=1ed65e476b8, topicName=政策)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=322359, createdName=bioon3, createdTime=Fri Jul 01 02:30:00 CST 2016, time=2016-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1591253, encodeId=7ed81591253d6, content=<a href='/topic/show?id=436d299e33d' target=_blank style='color:#2F92EE;'>#共享#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29973, encryptionId=436d299e33d, topicName=共享)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec1e17938205, createdName=chendoc248, createdTime=Fri Jul 01 02:30:00 CST 2016, time=2016-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1593836, encodeId=6d351593836b6, content=<a href='/topic/show?id=a8585e72779' target=_blank style='color:#2F92EE;'>#数据共享#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57727, encryptionId=a8585e72779, topicName=数据共享)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c28e18169649, createdName=dinorsor530, createdTime=Fri Jul 01 02:30:00 CST 2016, time=2016-07-01, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1735948, encodeId=a2b41e35948b9, content=<a href='/topic/show?id=21be3492589' target=_blank style='color:#2F92EE;'>#医疗大数据#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34925, encryptionId=21be3492589, topicName=医疗大数据)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Tue Feb 28 21:30:00 CST 2017, time=2017-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2045984, encodeId=1e9e20459841b, content=<a href='/topic/show?id=2cc92e76464' target=_blank style='color:#2F92EE;'>#健康医疗大数据#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27764, encryptionId=2cc92e76464, topicName=健康医疗大数据)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=685a124, createdName=muzishouyi, createdTime=Sat Jan 21 19:30:00 CST 2017, time=2017-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1807264, encodeId=656c180e2644b, content=<a href='/topic/show?id=bd19e94520e' target=_blank style='color:#2F92EE;'>#网售处方#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79452, encryptionId=bd19e94520e, topicName=网售处方)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/TnzXXl41yf6V8fHrDb5JdtxOgpaY6vplUhHtL8BzDh1xMtcap9H1IOlE8umxPGovhIuVkeGTY26eNUFCFaOheQ/132, createdBy=29702500197, createdName=ms6279672939590805, createdTime=Sat Apr 22 12:30:00 CST 2017, time=2017-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1677589, encodeId=a17e16e758997, content=<a href='/topic/show?id=51162e76305' target=_blank style='color:#2F92EE;'>#健康医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27763, encryptionId=51162e76305, topicName=健康医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2fd27558420, createdName=jiadan198791, createdTime=Tue Mar 07 08:30:00 CST 2017, time=2017-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1695594, encodeId=92bf16955945c, content=<a href='/topic/show?id=af2ae94539a' target=_blank style='color:#2F92EE;'>#网售处方药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79453, encryptionId=af2ae94539a, topicName=网售处方药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Wed Dec 07 17:30:00 CST 2016, time=2016-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1260185, encodeId=416c12601850b, content=<a href='/topic/show?id=1ed65e476b8' target=_blank style='color:#2F92EE;'>#政策#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57476, encryptionId=1ed65e476b8, topicName=政策)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=322359, createdName=bioon3, createdTime=Fri Jul 01 02:30:00 CST 2016, time=2016-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1591253, encodeId=7ed81591253d6, content=<a href='/topic/show?id=436d299e33d' target=_blank style='color:#2F92EE;'>#共享#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29973, encryptionId=436d299e33d, topicName=共享)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec1e17938205, createdName=chendoc248, createdTime=Fri Jul 01 02:30:00 CST 2016, time=2016-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1593836, encodeId=6d351593836b6, content=<a href='/topic/show?id=a8585e72779' target=_blank style='color:#2F92EE;'>#数据共享#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57727, encryptionId=a8585e72779, topicName=数据共享)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c28e18169649, createdName=dinorsor530, createdTime=Fri Jul 01 02:30:00 CST 2016, time=2016-07-01, status=1, ipAttribution=)]
    2016-07-01 bioon3
  7. [GetPortalCommentsPageByObjectIdResponse(id=1735948, encodeId=a2b41e35948b9, content=<a href='/topic/show?id=21be3492589' target=_blank style='color:#2F92EE;'>#医疗大数据#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34925, encryptionId=21be3492589, topicName=医疗大数据)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Tue Feb 28 21:30:00 CST 2017, time=2017-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2045984, encodeId=1e9e20459841b, content=<a href='/topic/show?id=2cc92e76464' target=_blank style='color:#2F92EE;'>#健康医疗大数据#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27764, encryptionId=2cc92e76464, topicName=健康医疗大数据)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=685a124, createdName=muzishouyi, createdTime=Sat Jan 21 19:30:00 CST 2017, time=2017-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1807264, encodeId=656c180e2644b, content=<a href='/topic/show?id=bd19e94520e' target=_blank style='color:#2F92EE;'>#网售处方#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79452, encryptionId=bd19e94520e, topicName=网售处方)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/TnzXXl41yf6V8fHrDb5JdtxOgpaY6vplUhHtL8BzDh1xMtcap9H1IOlE8umxPGovhIuVkeGTY26eNUFCFaOheQ/132, createdBy=29702500197, createdName=ms6279672939590805, createdTime=Sat Apr 22 12:30:00 CST 2017, time=2017-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1677589, encodeId=a17e16e758997, content=<a href='/topic/show?id=51162e76305' target=_blank style='color:#2F92EE;'>#健康医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27763, encryptionId=51162e76305, topicName=健康医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2fd27558420, createdName=jiadan198791, createdTime=Tue Mar 07 08:30:00 CST 2017, time=2017-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1695594, encodeId=92bf16955945c, content=<a href='/topic/show?id=af2ae94539a' target=_blank style='color:#2F92EE;'>#网售处方药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79453, encryptionId=af2ae94539a, topicName=网售处方药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Wed Dec 07 17:30:00 CST 2016, time=2016-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1260185, encodeId=416c12601850b, content=<a href='/topic/show?id=1ed65e476b8' target=_blank style='color:#2F92EE;'>#政策#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57476, encryptionId=1ed65e476b8, topicName=政策)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=322359, createdName=bioon3, createdTime=Fri Jul 01 02:30:00 CST 2016, time=2016-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1591253, encodeId=7ed81591253d6, content=<a href='/topic/show?id=436d299e33d' target=_blank style='color:#2F92EE;'>#共享#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29973, encryptionId=436d299e33d, topicName=共享)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec1e17938205, createdName=chendoc248, createdTime=Fri Jul 01 02:30:00 CST 2016, time=2016-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1593836, encodeId=6d351593836b6, content=<a href='/topic/show?id=a8585e72779' target=_blank style='color:#2F92EE;'>#数据共享#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57727, encryptionId=a8585e72779, topicName=数据共享)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c28e18169649, createdName=dinorsor530, createdTime=Fri Jul 01 02:30:00 CST 2016, time=2016-07-01, status=1, ipAttribution=)]
    2016-07-01 chendoc248
  8. [GetPortalCommentsPageByObjectIdResponse(id=1735948, encodeId=a2b41e35948b9, content=<a href='/topic/show?id=21be3492589' target=_blank style='color:#2F92EE;'>#医疗大数据#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34925, encryptionId=21be3492589, topicName=医疗大数据)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Tue Feb 28 21:30:00 CST 2017, time=2017-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2045984, encodeId=1e9e20459841b, content=<a href='/topic/show?id=2cc92e76464' target=_blank style='color:#2F92EE;'>#健康医疗大数据#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27764, encryptionId=2cc92e76464, topicName=健康医疗大数据)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=685a124, createdName=muzishouyi, createdTime=Sat Jan 21 19:30:00 CST 2017, time=2017-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1807264, encodeId=656c180e2644b, content=<a href='/topic/show?id=bd19e94520e' target=_blank style='color:#2F92EE;'>#网售处方#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79452, encryptionId=bd19e94520e, topicName=网售处方)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/TnzXXl41yf6V8fHrDb5JdtxOgpaY6vplUhHtL8BzDh1xMtcap9H1IOlE8umxPGovhIuVkeGTY26eNUFCFaOheQ/132, createdBy=29702500197, createdName=ms6279672939590805, createdTime=Sat Apr 22 12:30:00 CST 2017, time=2017-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1677589, encodeId=a17e16e758997, content=<a href='/topic/show?id=51162e76305' target=_blank style='color:#2F92EE;'>#健康医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27763, encryptionId=51162e76305, topicName=健康医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2fd27558420, createdName=jiadan198791, createdTime=Tue Mar 07 08:30:00 CST 2017, time=2017-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1695594, encodeId=92bf16955945c, content=<a href='/topic/show?id=af2ae94539a' target=_blank style='color:#2F92EE;'>#网售处方药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79453, encryptionId=af2ae94539a, topicName=网售处方药)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Wed Dec 07 17:30:00 CST 2016, time=2016-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1260185, encodeId=416c12601850b, content=<a href='/topic/show?id=1ed65e476b8' target=_blank style='color:#2F92EE;'>#政策#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57476, encryptionId=1ed65e476b8, topicName=政策)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=322359, createdName=bioon3, createdTime=Fri Jul 01 02:30:00 CST 2016, time=2016-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1591253, encodeId=7ed81591253d6, content=<a href='/topic/show?id=436d299e33d' target=_blank style='color:#2F92EE;'>#共享#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29973, encryptionId=436d299e33d, topicName=共享)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec1e17938205, createdName=chendoc248, createdTime=Fri Jul 01 02:30:00 CST 2016, time=2016-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1593836, encodeId=6d351593836b6, content=<a href='/topic/show?id=a8585e72779' target=_blank style='color:#2F92EE;'>#数据共享#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57727, encryptionId=a8585e72779, topicName=数据共享)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c28e18169649, createdName=dinorsor530, createdTime=Fri Jul 01 02:30:00 CST 2016, time=2016-07-01, status=1, ipAttribution=)]

相关资讯

WHO图解:抗生素耐药性信息图

世界提高抗生素认识周  抗生素耐药性的原因 抗生素耐药性:它如何传播 抗生素耐药性:您能做什么 抗生素耐药性:政策制定者能做什么 抗生素耐药性:卫生工作人员能做什么 抗生素耐药性:农业部门能做什么

NEJM:外科医生值班时间对患者预后有影响吗?

BACKGROUNDConcerns persist regarding the effect of current surgical resident duty-hour policies on patient outcomes, resident education, and resident well-being.Full Text of Background...METHODSWe c

**解读:卫计委规范医疗机构科室管理及医疗技术临床应用管理精神

今天上午国家卫计委医政医管局召开规范医疗机构科室管理及医疗技术临床应用管理视频会议。全国31个省市(自治区、直辖市)等卫生厅局处,省市县级医院负责人参加了会议。 会议内容大体汇报如下: 1,卫生行政部门要履行监管责任,规范依法执业,加强基层民营医疗机构管理力度,要尽快改进监管作风,做好卫生机构特别是民营医疗机构的监管,规范医疗机构的科室管理,特别是公立医疗机构的违规,坚决杜绝违规违法现

北大李玲教授:4万亿投入怎么养活不了200万医生?

“1978年,中国各级政府医疗费用投入一百亿;2003年,各级政府对医疗卫生投入是八百亿;去年,政府的投入一年就是一万亿。医改以来,政府已经投入四万亿。”1、医院到今天还在创收,这个机制要改为什么我们中国要搞医改?原因在八十年代中期。1949年建国的时候,医疗是福利事业,最开始没有,在50、60年代吃不饱饭的时候,全国建了人民医院、妇幼保健院等等公立医院,都是政府包办的。过去医生为什么不开大药

史上强大政策来了!比医闹入刑更有力!更靠谱!

导语:这是史上最强的维护医护权益的文件,不打马虎眼,不含糊其辞,立场鲜明。相比“医闹入刑”刑法九简单的几句话,但犯罪定义不明确,执行力弱,处罚力度不明确等,这次的文件更加令人振奋人心,畅快淋漓!3月30日傍晚,国家卫计委、中央综治办、公安部、司法部等四部委下发了《关于进一步做好维护医疗秩序工作的通知》,明确医疗纠纷责任未认定前,医疗机构不得赔钱息事;对多次到医疗机构无理纠缠或扬言报复医务人员的

12省份计生新政出台,产假最长半年

12省份计生新政出台,福建省产假最长180天。专家建议恢复“托儿所”,为全民二胎做保障。 (数据来源于各地公开发表的《人口与计划生育条例》及新闻报道) 为全面实施两孩政策,各地相继开始修订地方计生条例,目前,天津、浙江、宁夏等12省份的新计生条例已经出台。经人民网编辑梳理发现,不同省份产假从最长的180天到最短的128天,可相差近两个月之多。而对于百姓担心的两孩生育相关保障问题,多名专家围